06/24/2025 6:05 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2025 3:07 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2025 3:23 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2025 3:23 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2025 4:05 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025 4:25 PM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Wei Lin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025 8:22 AM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
05/15/2025 8:23 AM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025 8:24 AM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025 11:29 AM | JANUS HENDERSON GROUP PLC (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G/A | |
04/28/2025 5:27 PM | Clyburn Frank (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
Get the Latest News and Ratings for RVMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter.
|
03/24/2025 3:55 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 3:32 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 4:40 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wang Xiaolin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:40 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:41 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:42 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:43 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:43 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 4:42 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025 4:14 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025 3:47 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025 3:18 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:02 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:03 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:00 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:01 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wang Xiaolin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:01 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wei Lin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:02 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 6:02 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2025 3:44 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025 3:10 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2025 10:25 AM | JANUS HENDERSON GROUP PLC (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
01/22/2025 4:30 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 3:20 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024 3:50 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:09 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:06 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:07 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:07 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
12/16/2024 8:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 7:42 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 7:01 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 6:39 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 3:57 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2024 3:18 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/03/2024 8:37 PM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form FWP | |
12/02/2024 4:21 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
12/02/2024 6:30 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 3:20 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 9:52 AM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024 4:07 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024 3:05 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 3:10 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024 3:42 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:42 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:43 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024 3:30 PM | Patel Sushil (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 5:43 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2024 5:05 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:07 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:29 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:30 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:30 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 4:31 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 7:03 AM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:16 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:23 PM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Weber Barbara (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:33 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 3:33 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:16 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:17 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:17 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:18 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:18 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 6:06 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 5:41 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 5:22 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:37 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:15 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:24 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 3:23 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 3:15 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 3:48 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:07 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
08/02/2024 4:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 3:29 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 4:05 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
White House to reset Social Security? (Ad) Elon Musk's parting DOGE gift looks set to shock America...
A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.  And it could have a major impact on how you collect Social Security - Click here to understand what' |
07/15/2024 3:27 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 7:03 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 3:36 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:36 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 3:19 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:19 PM | Patel Sushil (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |